T1	Participants 139 232	patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA).
T2	Participants 242 281	Radiation Therapy Oncology Group (RTOG)
T3	Participants 319 371	patients with 1 but not 2 or 3 brain metastasis (BM)
T4	Participants 715 761	252 of the 331 patients were evaluable by GPA.
T5	Participants 762 792	Of those, 211 had lung cancer.
T6	Participants 793 829	Breast cancer patients were excluded
T7	Participants 962 978	treatment groups
T8	Participants 1707 1727	lung cancer patients
T9	Participants 1862 1884	patients with high GPA
T10	Participants 2079 2148	patients with multiple BM and high GPA when treated with WBRT and SRS
